#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA840412	A	Area under curve for plasma concentration after peroral administration at dose of 100 mg/kg for 1 day in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
2.	ALA840414	A	Area under curve for plasma concentration after peroral administration at dose of 100 mg/kg for 7 days in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
3.	ALA839557	A	Area under curve for plasma concentration after peroral administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	1	ALA1138791	organism-based format	Scientific Literature
4.	ALA840429	A	Area under curve or plasma concentration after intravenous administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	1	ALA1138791	organism-based format	Scientific Literature
5.	ALA838436	A	Maximum plasma concentration of compound after peroral administration at dose of 100 mg/kg for 1 days in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
6.	ALA838437	A	Maximum plasma concentration of compound after peroral administration at dose of 100 mg/kg for 7 days in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
7.	ALA838439	A	Maximum plasma concentration of compound after peroral administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	2	ALA1138791	organism-based format	Scientific Literature
8.	ALA838748	A	Maximum plasma concentration of compound after intravenous administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	1	ALA1138791	organism-based format	Scientific Literature
9.	ALA838488	A	Half life of compound after peroral administration at dose of 100 mg/kg for 1 day in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
10.	ALA838884	A	Half life of compound after peroral administration at dose of 100 mg/kg for 7 days in rats	Rattus norvegicus	1	ALA1138791	organism-based format	Scientific Literature
11.	ALA838946	A	Half life of compound after peroral administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	2	ALA1138791	organism-based format	Scientific Literature
12.	ALA839909	A	Half life of compound after intravenous administration at dose of 80 mg/kg for 10 days in mouse	Mus musculus	1	ALA1138791	organism-based format	Scientific Literature
13.	ALA830487	F	Mean graph mid point value for cytotoxic activity against human cancer cell lines was determined	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
14.	ALA824913	F	Growth inhibitory activity against human colon HT-29 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
15.	ALA836362	F	Growth inhibitory activity against human breast MCF-7 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
16.	ALA836363	F	Growth inhibitory activity against human colon SW620 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
17.	ALA836368	F	Growth inhibitory activity against human colon HCT116 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
18.	ALA825888	F	Growth inhibitory activity against human lung NCI-H522 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
19.	ALA836373	F	Growth inhibitory activity against human renal RXF-393 cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature
20.	ALA836398	F	Growth inhibitory activity against human leukemia HL-60 (TB) cell line	Homo sapiens	4	ALA1138791	cell-based format	Scientific Literature